Synthomer plc (LON:SYNT)

London flag London · Delayed Price · Currency is GBP · Price in GBX
45.10
+0.25 (0.56%)
At close: Apr 28, 2026
-47.56%
Market Cap 73.32M
Revenue (ttm) 1.89B
Net Income (ttm) -83.60M
Shares Out 163.47M
EPS (ttm) -0.51
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 293,577
Average Volume 991,653
Open 46.80
Previous Close 44.85
Day's Range 45.00 - 46.80
52-Week Range 16.70 - 123.74
Beta 0.57
RSI 54.79
Earnings Date Apr 30, 2026

About Synthomer

Synthomer plc manufactures and supplies specialised polymers and ingredients for coatings, construction, adhesives, and health and protection sectors. The company offers adhesives, such as PSA labels, and packaging and specialty tapes; tape saturants, release coating, wood working, sealants, wet glues, hygiene, and contact adhesives; packaging and assembly hot melt adhesives; and liquid polybutadiene products under the LITHENE brand. It also provides architectural, intumescent, metal, and wood coating, as well as masonry, protective film, polye... [Read more]

Sector Materials
Founded 1863
Employees 3,900
Stock Exchange London Stock Exchange
Ticker Symbol SYNT
Full Company Profile

Financial Performance

In 2024, Synthomer's revenue was 1.99 billion, an increase of 2.38% compared to the previous year's 1.94 billion. Losses were -72.60 million, 8.36% more than in 2023.

Financial Statements

News

Synthomer Earnings Call Transcript: H1 2025

Gross margin and EBITDA improved despite an 8.8% revenue decline, driven by cost reductions and portfolio simplification. Demand remains subdued due to tariffs and geopolitical uncertainty, but positive free cash flow is expected in H2, with leverage reduction a key focus.

9 months ago - Transcripts

Synthomer Earnings Call Transcript: H2 2024

Revenue, EBITDA, and EBIT all grew in 2024 despite weak end-market demand, with all divisions posting volume gains and specialty products now 55% of revenues. Positive free cash flow and further deleveraging are expected in 2025, supported by cost actions, portfolio shifts, and disciplined capital allocation.

1 year ago - Transcripts

Synthomer Earnings Call Transcript: H1 2024

H1 2024 saw revenue, earnings, and EPS growth, driven by volume recovery and self-help measures, with stable trading and improved margins across all divisions. Strategic transformation and divestments continue, while leverage and liquidity remain within targets.

1 year ago - Transcripts

Synthomer Transcript: CMD 2022

3 years ago - Transcripts